Imperial College London

Emeritus ProfessorAndrewGeorge

Faculty of MedicineDepartment of Surgery & Cancer

Emeritus Professor





Hammersmith HospitalHammersmith Campus





Andrew George did his first degree at the University of Cambridge (1984, Natural Sciences, Part II Pathology), before going on to the Tenovus Laboratories in the University of Southampton to do his PhD with Professor Freda Stevenson (1987). He worked on the use of idiotypic immunoglobulin as a vaccination strategy for B cell lymphoma. He was awarded a Beit Memorial Fellowship and stayed in Southampton for his first postdoctoral period, before going to Dr David Segal’s laboratory in the Experimental Immunology Branch of the National Cancer Institute, NIH, Bethesda, USA. He worked on using recombinant techniques to generate novel antibody molecules. In 1992 he returned to the UK as a lecturer at the Royal Postgraduate Medical School, Hammersmith Hospital (now part of the Faculty of Medicine of Imperial College London). He is Professor of Molecular Immunology in the Department.

Andrew’s research has sought to understand and manipulate the immune system in order to treat disease, in particular to prevent the rejection of transplanted organs. He has also used mathematical models to understand how the immune system functions. During 2003-2006 he was BBSRC Research Leave Fellow. He is on the Editorial Board of Transplantation and is Chair of the Scientific Panel of Action Medical Research.

In addition to his research, he has been involved in the ethical conduct and regulation of research. He is currently Chair of the UK’s National Research Ethics Advisors’ Panel and is also on the Clinical Trials Expert Advisory Group for the Commission of Human Medicines/MHRA.

Andrew is Director of the Graduate School and the School of Professional Development. Until 2003 he was course organiser of the MSc in Immunology, and in 2000 and 2004 was given an Imperial College Award for Excellence in Teaching. He has also been Head of Science BSc courses for the Faculty of Medicine.

He is a member of the British Society for Immunology, British Transplantation Society and the Transplantation Society and is a Fellow of the Royal College of Pathologists, the Higher Education Academy, the Society of Biology and the Royal Society for the Encouragement of Arts, Manufactures & Commerce. He is also a Governor of Richmond Adult Community College.



Yasmin H, Saha S, Butt MT, et al., 2021, SARS-CoV-2: Pathogenic Mechanisms and Host Immune Response., Adv Exp Med Biol, Vol:1313, ISSN:0065-2598, Pages:99-134

Urch CE, George AJT, 2020, COVID-19: LESS HASTE, MORE SAFETY Let's stop talking about covid-safe and covid-secure-it's covid-mitigated, Bmj-british Medical Journal, Vol:370, ISSN:1756-1833

Zhao H, Alam A, Pac Soo A, et al., 2018, Ischemia-reperfusion injury reduces long term renal graft survival: mechanism and beyond, Ebiomedicine, Vol:28, ISSN:2352-3964, Pages:31-42

Chatterjee J, Dai W, Abd Aziz NH, et al., 2016, Clinical use of programmed cell death-1 (PD-1) and its ligand (PD-L1) expression as discriminatory and predictive markers in ovarian cancer, Clinical Cancer Research, Vol:23, ISSN:1557-3265, Pages:3453-3460

Teo PY, Yang C, Whilding LM, et al., 2015, Ovarian Cancer Immunotherapy Using PD-L1 siRNA Targeted Delivery from Folic Acid-Functionalized Polyethylenimine: Strategies to Enhance T Cell Killing, Advanced Healthcare Materials, Vol:4, ISSN:2192-2640, Pages:1180-1189

More Publications